ReP USP - Resultado da busca

Artigo de periodico
Protein Arginylation is regulated during SARS-CoV-2 infection (2023)
Silva, Janaina Macedo da ; Fernandes, Livia Rosa ; Gomes, Vinicius de Morais ; Santiago, Veronica Feijoli ; Santos, Deivid Martins ; Molnar Catarina Maria Stanischesk ; Barboza, Bruno Rafael ; Souza, Edmarcia Elisa de ; Marques, Rodolfo Ferreira ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias ; Wrenger, Carsten ; Marie, Suely Kazue Nagahashi ; Palmisano, Giuseppe
Source: Viruses. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, ENZIMAS, METABOLISMO DE PROTEÍNA, COVID-19, PROTEÍNAS, LISOSSOMOS, MACRÓFAGOS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Janaina Macedo da et al. Protein Arginylation is regulated during SARS-CoV-2 infection. Viruses, v. 15, n. 2, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15020290. Acesso em: 03 jun. 2024.
APA
Silva, J. M. da, Fernandes, L. R., Gomes, V. de M., Santiago, V. F., Santos, D. M., Molnar Catarina Maria Stanischesk,, et al. (2023). Protein Arginylation is regulated during SARS-CoV-2 infection. Viruses, 15( 2), 1-25. doi:10.3390/v15020290
NLM
Silva JM da, Fernandes LR, Gomes V de M, Santiago VF, Santos DM, Molnar Catarina Maria Stanischesk, Barboza BR, Souza EE de, Marques RF, Boscardin SB, Durigon EL, Marinho CRF, Wrenger C, Marie SKN, Palmisano G. Protein Arginylation is regulated during SARS-CoV-2 infection [Internet]. Viruses. 2023 ; 15( 2): 1-25.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3390/v15020290
Vancouver
Silva JM da, Fernandes LR, Gomes V de M, Santiago VF, Santos DM, Molnar Catarina Maria Stanischesk, Barboza BR, Souza EE de, Marques RF, Boscardin SB, Durigon EL, Marinho CRF, Wrenger C, Marie SKN, Palmisano G. Protein Arginylation is regulated during SARS-CoV-2 infection [Internet]. Viruses. 2023 ; 15( 2): 1-25.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3390/v15020290
Artigo de periodico
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections (2023)
Reinke, Patrick Y. A ; Souza, Edmarcia Elisa de ; Günther, Sebastian ; Falke, Sven ; Lieske, Julia ; Ewert, Wiebke ; Loboda, Jure ; Herrmann, Alexander ; Mashhour, Aida Rahmani ; Karničar, Katarina ; Usenik, Aleksandra ; Lindič, Nataša ; Sekirnik, Andreja; Botosso, Viviane Fongaro ; Santelli, Glaucia Maria Machado ; Kapronezai, Josana ; Araujo, Marcelo Valdemir de ; Pereira, Taiana Tainá Silva ; Souza Filho, Antonio Francisco de ; Tavares, Mariana Silva; Flórez-Álvarez, Lizdany ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Giaretta, Paula Roberta ; Heinemann, Marcos Bryan ; Hauser, Maurice; Seychell, Brandon ; Böhler, Hendrik; Rut, Wioletta ; Drag, Marcin ; Beck, Tobias ; Cox, Russell ; Chapman, Henry N. ; Betzel, Christian ; Brehm, Wolfgang ; Hinrichs, Winfried ; Ebert, Gregor ; Latham, Sharissa L. ; Guimarães, Ana Marcia de Sá ; Turk, Dusan ; Wrenger, Carsten ; Meents, Alke
Source: Communications Biology. Unidades: ICB, FMVZ
Subjects: COVID-19, INIBIDORES DE ENZIMAS, ENZIMAS PROTEOLÍTICAS, ANTIVIRAIS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REINKE, Patrick Y. A et al. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, v. 6, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1038/s42003-023-05317-9. Acesso em: 03 jun. 2024.
APA
Reinke, P. Y. A., Souza, E. E. de, Günther, S., Falke, S., Lieske, J., Ewert, W., et al. (2023). Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, 6, 1-13. doi:10.1038/s42003-023-05317-9
NLM
Reinke PYA, Souza EE de, Günther S, Falke S, Lieske J, Ewert W, Loboda J, Herrmann A, Mashhour AR, Karničar K, Usenik A, Lindič N, Sekirnik A, Botosso VF, Santelli GMM, Kapronezai J, Araujo MV de, Pereira TTS, Souza Filho AF de, Tavares MS, Flórez-Álvarez L, Oliveira DBL de, Durigon EL, Giaretta PR, Heinemann MB, Hauser M, Seychell B, Böhler H, Rut W, Drag M, Beck T, Cox R, Chapman HN, Betzel C, Brehm W, Hinrichs W, Ebert G, Latham SL, Guimarães AM de S, Turk D, Wrenger C, Meents A. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections [Internet]. Communications Biology. 2023 ; 6 1-13.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1038/s42003-023-05317-9
Vancouver
Reinke PYA, Souza EE de, Günther S, Falke S, Lieske J, Ewert W, Loboda J, Herrmann A, Mashhour AR, Karničar K, Usenik A, Lindič N, Sekirnik A, Botosso VF, Santelli GMM, Kapronezai J, Araujo MV de, Pereira TTS, Souza Filho AF de, Tavares MS, Flórez-Álvarez L, Oliveira DBL de, Durigon EL, Giaretta PR, Heinemann MB, Hauser M, Seychell B, Böhler H, Rut W, Drag M, Beck T, Cox R, Chapman HN, Betzel C, Brehm W, Hinrichs W, Ebert G, Latham SL, Guimarães AM de S, Turk D, Wrenger C, Meents A. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections [Internet]. Communications Biology. 2023 ; 6 1-13.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1038/s42003-023-05317-9
Artigo de periodico-carta/editorial
Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics (2023)
Botosso, Viviane Fongaro ; Durigon, Edison Luiz ; Souza, Edmarcia Elisa de
Source: Frontiers in Cellular and Infection Microbiology. Unidade: ICB
Subjects: MICROBIOLOGIA, VÍRUS, ANTIVIRAIS, INFLUENZA, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOTOSSO, Viviane Fongaro e DURIGON, Edison Luiz e SOUZA, Edmarcia Elisa de. Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics. Frontiers in Cellular and Infection Microbiology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fcimb.2023.1182522. Acesso em: 03 jun. 2024. , 2023
APA
Botosso, V. F., Durigon, E. L., & Souza, E. E. de. (2023). Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics. Frontiers in Cellular and Infection Microbiology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.3389/fcimb.2023.1182522
NLM
Botosso VF, Durigon EL, Souza EE de. Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics [Internet]. Frontiers in Cellular and Infection Microbiology. 2023 ; 13 1-2.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3389/fcimb.2023.1182522
Vancouver
Botosso VF, Durigon EL, Souza EE de. Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics [Internet]. Frontiers in Cellular and Infection Microbiology. 2023 ; 13 1-2.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3389/fcimb.2023.1182522
Artigo de periodico
Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system (2022)
Miranda, Renata Rank ; Ferreira, Natália Noronha ; Souza, Edmarcia Elisa de ; Lins, Paula Maria Pincela ; Ferreira, Leonardo Miziara Barboza; Kruger, Arne ; Cardoso, Valéria Maria de Oliveira; Durigon, Edison Luiz ; Wrenger, Carsten ; Zucolotto, Valtencir
Source: ACS Applied Bio Materials. Unidades: ICB, IFSC
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, PLANEJAMENTO DE FÁRMACOS, NANOPARTÍCULAS, NANOTECNOLOGIA, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Renata Rank et al. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system. ACS Applied Bio Materials, v. 5, n. 7, p. 3371-3383, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsabm.2c00349. Acesso em: 03 jun. 2024.
APA
Miranda, R. R., Ferreira, N. N., Souza, E. E. de, Lins, P. M. P., Ferreira, L. M. B., Kruger, A., et al. (2022). Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system. ACS Applied Bio Materials, 5( 7), 3371-3383. doi:10.1021/acsabm.2c00349
NLM
Miranda RR, Ferreira NN, Souza EE de, Lins PMP, Ferreira LMB, Kruger A, Cardoso VM de O, Durigon EL, Wrenger C, Zucolotto V. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system [Internet]. ACS Applied Bio Materials. 2022 ; 5( 7): 3371-3383.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1021/acsabm.2c00349
Vancouver
Miranda RR, Ferreira NN, Souza EE de, Lins PMP, Ferreira LMB, Kruger A, Cardoso VM de O, Durigon EL, Wrenger C, Zucolotto V. Modulating fingolimod (FTY720) Anti-SARS-CoV-2 activity using a PLGA-Based drug delivery system [Internet]. ACS Applied Bio Materials. 2022 ; 5( 7): 3371-3383.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1021/acsabm.2c00349
Artigo de periodico
Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential (2022)
Flórez-Álvarez, Lizdany ; Souza, Edmarcia Elisa de ; Botosso, Viviane Fongaro ; Oliveira, Danielle Bruna Leal de ; Ho, Paulo Lee ; Taborda, Carlos Pelleschi ; Palmisano, Giuseppe ; Capurro, Margareth de Lara ; Pinho, Joao Renato Rebello ; Ferreira, Helena Lage ; Minoprio, Paola Marcella Camargo ; Arruda, Eurico; Ferreira, Luís Carlos de Souza ; Wrenger, Carsten ; Durigon, Edison Luiz
Source: Frontiers in Microbiology. Unidades: ICB, FM, FZEA, FMRP
Subjects: VIROLOGIA, DOENÇAS INFECCIOSAS, FEBRE HEMORRÁGICA COM SÍNDROME RENAL, INFLUENZA, PARASITOLOGIA, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FLÓREZ-ÁLVAREZ, Lizdany et al. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Frontiers in Microbiology, v. 13, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2022.1040093. Acesso em: 03 jun. 2024.
APA
Flórez-Álvarez, L., Souza, E. E. de, Botosso, V. F., Oliveira, D. B. L. de, Ho, P. L., Taborda, C. P., et al. (2022). Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Frontiers in Microbiology, 13, 1-16. doi:10.3389/fmicb.2022.1040093
NLM
Flórez-Álvarez L, Souza EE de, Botosso VF, Oliveira DBL de, Ho PL, Taborda CP, Palmisano G, Capurro M de L, Pinho JRR, Ferreira HL, Minoprio PMC, Arruda E, Ferreira LC de S, Wrenger C, Durigon EL. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential [Internet]. Frontiers in Microbiology. 2022 ; 13 1-16.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3389/fmicb.2022.1040093
Vancouver
Flórez-Álvarez L, Souza EE de, Botosso VF, Oliveira DBL de, Ho PL, Taborda CP, Palmisano G, Capurro M de L, Pinho JRR, Ferreira HL, Minoprio PMC, Arruda E, Ferreira LC de S, Wrenger C, Durigon EL. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential [Internet]. Frontiers in Microbiology. 2022 ; 13 1-16.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3389/fmicb.2022.1040093
Artigo de periodico
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease (2022)
Srinivasan, Vasundara ; Brognaro, Hévila ; Prabhu, Prince R.; Souza, Edmarcia Elisa de ; Günther, Sebastian ; Reinke, Patrick Y. A.; Barra, Angélica Luana Carrilho ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Wrenger, Carsten
Source: Communications Biology. Unidades: ICB, IFSC
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ANTIVIRAIS, COVID-19, ATIVAÇÃO ENZIMÁTICA, ENZIMAS PROTEOLÍTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SRINIVASAN, Vasundara et al. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Communications Biology, v. 5, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1038/s42003-022-03737-7. Acesso em: 03 jun. 2024.
APA
Srinivasan, V., Brognaro, H., Prabhu, P. R., Souza, E. E. de, Günther, S., Reinke, P. Y. A., et al. (2022). Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Communications Biology, 5, 1-12. doi:10.1038/s42003-022-03737-7
NLM
Srinivasan V, Brognaro H, Prabhu PR, Souza EE de, Günther S, Reinke PYA, Barra ALC, Machado RRG, Durigon EL, Wrenger C. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease [Internet]. Communications Biology. 2022 ; 5 1-12.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1038/s42003-022-03737-7
Vancouver
Srinivasan V, Brognaro H, Prabhu PR, Souza EE de, Günther S, Reinke PYA, Barra ALC, Machado RRG, Durigon EL, Wrenger C. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease [Internet]. Communications Biology. 2022 ; 5 1-12.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1038/s42003-022-03737-7

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration